STA-Liatest D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion
On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA-Liatest D-Di for the exclusion of the diagnosis of Deep Vein Thrombosis (DVT) on data reported from the multi-national, DiET study. Exclusion of the diagnosis of Pulmonary embolism (PE) was previously 510(k) cleared in 2014.
Read more
Results of the DiET Study have been recently published in Blood coagulation fibrinolysis, July 2016.
Read more
Stago’s “Practical Manual” collection - volume 3 has arrived!
The Practical Manual collection, a series of practical/scientific booklets in English, launched 3 years ago by Stago, has grown! This year being the centenary of the discovery of heparin, volume 3 is naturally devoted to parenteral anticoagulants.
Read more
Stago Scientific Meeting (November 19, 2014)
This symposium has been a great opportunity for Stago to invite key customers from all new affiliates in Europe. Around 90 customers joined us in Enghien-les-Bains a famous spa resort and a well-to-do suburb of Paris for sharing scientific sessions as well as the launch of a new analyser of the Max Generation, the STA R Max.
Read more
ISHBT (Indian Society of Haematology and Blood Transfusion)
Stago opened an Indian office 18 months ago and participated for the second time in the annual conference of the ISHBT, the 55th edition of which was held in Hyderabad from 6 to 8 November 2014.
Read more